Sales & Marketing Sponsored Company Profile: Healthcare Consultancy Group Healthcare Consultancy Group Reimagining medical communications
Sales & Marketing Sponsored 12 Questions with Matt D’Auria Matt D’Auria is a talent-centric leader who has been building and leading medical communications teams for over 20 years.
News Intellia files CRISPR drug after historic phase 3 readout Intellia has reported the first-ever phase 3 results with an in vivo gene-editing therapy, CRISPR-based lonvo-z for hereditary angioedema.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.